Atypical depression: useful concept, but it's time to revise the DSM-IV criteria
- PMID: 19741592
- DOI: 10.1038/npp.2009.100
Atypical depression: useful concept, but it's time to revise the DSM-IV criteria
Abstract
Stewart et al (2009) have outlined the evidence in support of the validity of the DSM-IV definition of the 'With Atypical Features' episode specifier. Although recognizing the historical significance and clinical utility of the concept of atypical depression, this article takes issue with the DSM-IV criteria. It is concluded that mood reactivity, the A or obligative criterion, is neither significantly associated with the other symptomatic criteria nor useful to diagnose atypical depression, and thus should be eliminated. Problems with operationalization, specification, and reliability of ratings of the diagnostic criteria further limit validity. Despite these limitations in classification, many of the features associated with atypical depression are linked to an early onset of affective illness, including trait-like interpersonal sensitivity, comorbid social anxiety and agoraphobia, a history of childhood physical or sexual trauma, and indicators of the 'soft' side of the bipolar spectrum. Neurophysiologic studies also suggest that chronic, early-onset atypical depressions differ from both melancholia and normality. Re-analyses of the Columbia group's seminal studies suggest that preferential response to phenelzine vs imipramine--arguably the strongest validator of atypical depression--similarly appears to be limited to patients with chronic, early-onset syndromes. The criteria for atypical depression need to be revised in DSM-V, including sharpening the operational definitions for the specific symptoms. The importance of age of onset and comorbid anxiety warrant further study. Research examining the validity of a subform of atypical depression characterized by trait-like interpersonal sensitivity and a chronic, early-onset course may further enhance the clinical utility of the DSM-V classification.
Comment on
-
DSM-IV depression with atypical features: is it valid?Neuropsychopharmacology. 2009 Dec;34(13):2625-32. doi: 10.1038/npp.2009.99. Epub 2009 Sep 2. Neuropsychopharmacology. 2009. PMID: 19727067 Review.
Similar articles
-
[The modern concept of atypical depression: four definitions].Seishin Shinkeigaku Zasshi. 2010;112(1):3-22. Seishin Shinkeigaku Zasshi. 2010. PMID: 20184236 Review. Japanese.
-
DSM-IV depression with atypical features: is it valid?Neuropsychopharmacology. 2009 Dec;34(13):2625-32. doi: 10.1038/npp.2009.99. Epub 2009 Sep 2. Neuropsychopharmacology. 2009. PMID: 19727067 Review.
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
-
Recognition and diagnosis of atypical depression.J Clin Psychiatry. 2007;68 Suppl 8:11-6. J Clin Psychiatry. 2007. PMID: 17640153 Review.
-
Atypical depression: current status and relevance to melancholia.Acta Psychiatr Scand Suppl. 2007;(433):58-71. doi: 10.1111/j.1600-0447.2007.00964.x. Acta Psychiatr Scand Suppl. 2007. PMID: 17280572 Review.
Cited by
-
Effect of rejection sensitivity on the development of anxious-depressive attack in Japanese outpatients: The mediating roles of rumination, social anxiety, and depressive symptoms.Front Psychol. 2022 Nov 30;13:1016879. doi: 10.3389/fpsyg.2022.1016879. eCollection 2022. Front Psychol. 2022. PMID: 36532964 Free PMC article.
-
Moving on With Monoamine Oxidase Inhibitors.Focus (Am Psychiatr Publ). 2021 Jan;19(1):50-52. doi: 10.1176/appi.focus.20200046. Epub 2021 Jan 25. Focus (Am Psychiatr Publ). 2021. PMID: 34483767 Free PMC article. No abstract available.
-
Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?J Clin Med. 2020 Dec 12;9(12):4018. doi: 10.3390/jcm9124018. J Clin Med. 2020. PMID: 33322667 Free PMC article.
-
Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design.Antioxidants (Basel). 2020 Aug 6;9(8):714. doi: 10.3390/antiox9080714. Antioxidants (Basel). 2020. PMID: 32781750 Free PMC article. Review.
-
The effects of ketamine on typical and atypical depressive symptoms.Acta Psychiatr Scand. 2020 Nov;142(5):394-401. doi: 10.1111/acps.13216. Epub 2020 Aug 6. Acta Psychiatr Scand. 2020. PMID: 32677051 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources